Savara Pharmaceuticals
SVRA
#6301
Rank
S$0.80 B
Marketcap
$4.92
Share price
4.72%
Change (1 day)
4.64%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -$0.38

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.37. In 2022 the company made an earnings per share (EPS) of -$0.33 an increase over its 2021 EPS that were of -$0.44.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.3817.08%
2022-$0.33-26.47%
2021-$0.44-59.52%
2020-$1.10-56.48%
2019-$2.522.66%
2018-$2.45-38.56%
2017-$3.99-71.06%
2016-$13.80-37.06%
2015-$21.924.35%
2014-$21.01-25.81%
2013-$28.31-8.82%
2012-$31.05-27.66%
2011-$42.93-58.41%
2010-$103.21-86%
2009-$737.074.13%
2008-$707.8424%
2007-$570.84-35.9%
2006-$890.5195%
2005-$456.6753.85%
2004-$296.8444.44%
2003-$205.50-40%
2002-$342.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.30 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.35-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA